RARA CRAFT DATABASE for FDA Medical Devices
510(k)K222386

FDA DEVICE FACTS

Visionbody

Vb Technologies AG

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEFebruary 24, 2023PRODUCT CODENGX

Indications for use

The Visionbody System is a device intended to stimulate healthy muscles in order to improve or facilitate muscle performance. It is to be used by adults only. The Visionbody System is not intended to be used in conjunction with therapy or treatment of medical diseases or medical conditions of any kind. None of the training programs or operational parameters are designed to target injured or ailing muscles and its use on such muscles is contraindicated. The Visionbody System's electrical impulses allow the triggering of action potentials on motoneurons of motor nerves (excitations). These excitations of motoneurons are transmitted to the muscle fibers via the motor endplate where they generated mechanical muscle fiber responses that correspond to muscle work. Depending on the parameters of the electrical impulses (pulse frequency, duration of contraction, duration of rest, total session duration), different types of muscle work can be imposed on the stimulated muscles. Non-Clinical Data: Non-clinical product evaluation to demonstrate safety and effectiveness was conducted. Non-clinical testing includes:

• Risk Management: Software Usability and Risk Analysis were done using worse-case assumptions to verify user interface, safety features and satisfactory performance.

• Electrical Safety Testing IEC 60601 -1:2005 + A1:2012 and EN 60601 -1:2006 + A2:2013 to demonstrate electrical safety of the device.

• Electromagnetic Compatibility IEC 60601 -1-2:2015 to demonstrate the device does not interfere or interact with surrounding electromagnetic equipment.

• Electrical Safety and Essential Performance of Nerve and Muscle Stimulators Testing IEC 60601-2-10:2016

• Biocompatibility: Biocompatibility analysis of the patient contact materials was conducted for biosafety. The conductive cream has previously received market clearance.

• Software verification and validation testing were conducted on the Visionbody system an d documentation was provided as recommended by FDA’s Guidance for Industry and FDA Staff, “Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices.” The software for this device was considered as a “moderate” level of concern, since a failure or latent flaw in the software would lead to a delayed delivery of appropriate medical care. Documentation includes level of concern, software requirements and specifications, design architecture, risk analysis and software validation and verification.

• Performance Testing was conducted on the Visionbody system to verify performance as per requirements and specifications.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 19, 2026